Literature DB >> 19240045

Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis.

Vesna D Stojanovic1, Aleksandra R Doronjski, Slobodan D Spasojevic, Vesna S Pavlovic, Marko M Nikolic, Branka B Kovacevic.   

Abstract

Based on case history and clinical and electrophysiological examinations, the authors report on a case of an 8-year-old girl who was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy. The disease was complicated by deafness and kidney fibrosis. During treatment with methylprednisolone and intravenous immunoglobulin, followed by mycophenolate mofetil, prompt improvement of neurological findings occurred. The improvement of hearing was poor. Because the pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy has still not been clear, and on the grounds of several cases of chronic inflammatory demyelinating polyradiculoneuropathy conjoined with the kidney disease described in literature (glomerulopathy, interstitial nephritis), every patient with chronic inflammatory demyelinating polyradiculoneuropathy needs to undergo the urinalyses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240045     DOI: 10.1177/0883073808331353

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Chronic inflammatory demyelinating polyneuropathy: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials.

Authors:  Giuseppe Magliulo; Giannicola Iannella; Alessandra Manno; Laura Libonati; Emanuela Onesti; Annarita Vestri; Danilo Alunni Fegatelli; Diletta Angeletti; Annalisa Pace; Giampiero Gulotta; Silvia Gagliardi; Maurizio Inghilleri
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-27       Impact factor: 2.503

2.  Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies and questions.

Authors:  Jay Desai; Leigh Ramos-Platt; Wendy G Mitchell
Journal:  Ann Indian Acad Neurol       Date:  2015 Jul-Sep       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.